磁共振成像获得的肝脏细胞外容积分数可定量分期肝纤维化:非酒精性脂肪性肝炎猴模型的验证研究
本研究为前瞻性动物实验,纳入48只食蟹猴(17只健康、31只NASH),评估肝脏细胞外容积(LECV)对肝纤维化分期的诊断价值。LECV与病理纤维化评分强相关(r=0.949),诊断肝纤维化的AUC为0.945~1,作者认为LECV可能作为无创生物标志物用于定量和区分非重度肝纤维化(分期≤F3),而低密度脂蛋白和胆固醇可能不适用于此目的。
要点
- LECV与病理纤维化评分强相关(r=0.949;p<0.0001),诊断肝纤维化AUC为0.945~1。
- LECV在10只猴中重复性极佳(变异系数=2.01%),读者间一致性良好(组内相关系数=0.79)。
- 新纤维化评分图似乎能更好地空间评估肝纤维化,可能最终有助于诊断肝纤维化分布。
关键影像表现/征象
- LECV与病理纤维化评分强相关(r=0.949;p<0.0001)。
- LECV与低密度脂蛋白相关(r=0.72;p<0.0001),与胆固醇相关(r=0.70;p<0.0001)。
- 新纤维化评分图似乎能更好地空间评估肝纤维化,可能最终有助于诊断肝纤维化分布。
诊断标准与关键数值
- LECV诊断肝纤维化的ROC曲线下面积为0.945~1(p<0.001)。
- LECV在全部猴中读者间一致性组内相关系数为0.79,在10只猴中重复性变异系数为2.01%。
- LECV与病理纤维化评分强相关(r=0.949;p<0.0001)。
临床应用与阅片要点
- 作者认为LECV可能作为无创生物标志物用于定量和区分非重度肝纤维化(分期≤F3)。
- 作者认为循环血清标志物低密度脂蛋白和胆固醇可能不适用于该目的。
- 新纤维化评分图似乎能更好地空间评估肝纤维化,可能最终有助于诊断肝纤维化分布。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study was to evaluate the diagnostic value of liver extracellular volume (LECV) for the staging of liver fibrosis in a cynomolgus monkey model of nonalcoholic steatohepatitis (NASH).
METHODS: Forty-eight cynomolgus monkeys were enrolled in this prospective study. There are 17 healthy monkeys and 31 monkeys with NASH. Ten of these monkeys were used for repeatability assessment. The remaining 38 monkeys were used to compare LECV with other indicators including pathology fibrosis score, native T1, and serum chemical indexes by Spearman, Pearson correlation test, and ROC curves. The inter-reader variability was assessed by interclass correlation. The repeatability measurement of LECV was analyzed using Bland-Altman plots and the coefficient of variation. Partial correlation analysis was performed to assess the effects of fat content and inflammation scores on the correlation between LECV/T1 and liver fibrosis score.
RESULTS: This study demonstrated a good intra-reader agreement (intraclass correlation = 0.79) of LECV in all monkeys and an excellent repeatability in 10 monkeys (coefficient of variation = 2.01%). The LECV has a strong correlation with the fibrosis score (r = 0.949; p < 0.0001), low-density lipoprotein (r = 0.72; p < 0.0001), and cholesterol (r = 0.70; p < 0.0001). LECV showed high diagnostic efficacy in the diagnosis of liver fibrosis (area under the curve of ROC, 0.945~1; p < 0.001).
CONCLUSIONS: LECV may serve as a noninvasive valuable biomarker for the quantification and differentiating of the non-severe liver fibrosis (stage ≤ F3). However, circulating serum markers low-density lipoprotein and cholesterol (CHO) may not serve for this purpose.
KEY POINTS: • This paper demonstrated the excellent repeatability (intraclass correlation coefficient = 0.79) of LECV in monkey animal model. • LECV-MRI has a strong correlation with histopathological fibrosis score stage (r = 0.949; p < 0.0001) and shows high diagnostic efficacy in the staging of non-severe liver fibrosis (the area under ROC curve ≥ 0.945). • The new fibrosis score maps appeared to provide a better imaging tool for the spatial assessment of liver fibrosis. It may eventually facilitate the diagnosis of liver fibrosis distribution.
引用
- Lyu L, Liu XL, Rui MP, et al. Liver extracellular volume fraction values obtained with magnetic resonance imaging can quantitatively stage liver fibrosis: a validation study in monkeys with nonalcoholic steatohepatitis. Eur Radiol. 2020. PMID: 32377814. doi:10.1007/s00330-020-06902-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。